Eisai, Pfizer sales and marketing update

Eisai's Eisai Inc. subsidiary (Teaneck, N.J.) received exclusive U.S. promotion rights to PFE's Fragmin dalteparin, a subcutaneous anti-coagulant. Fragmin is approved in the U.S. to prevent deep vein...